Literature DB >> 24041695

Inhibition of fatty acid synthase suppresses U-2 OS cell invasion and migration via downregulating the activity of HER2/PI3K/AKT signaling pathway in vitro.

Tao Fang Wang1, Heng Wang, Ai Fen Peng, Qing Feng Luo, Zhi Li Liu, Rong Ping Zhou, Song Gao, Yang Zhou, Wen Zhao Chen.   

Abstract

FASN plays an important role in the malignant phenotype of various tumors. Our previous studies show that inhibition FASN could induce apoptosis and inhibit proliferation in human osteosarcoma (OS) cell in vivo and vitro. The aim in this study was to investigate the effect of inhibition FASN on the activity of HER2/PI3K/AKT axis and invasion and migration of OS cell. The expression of FASN, HER2 and p-HER2(Y1248) proteins was detected by immunohistochemistry in OS tissues from 24 patients with pulmonary metastatic disease, and the relationship between FASN and p-HER2 as well as HER2 was investigated. The results showed that there was a positive correlation between FASN and HER2 as well as p-HER2 protein expression. The U-2 OS cells were transfected with either the FASN specific RNAi plasmid or the negative control RNAi plasmid. FASN mRNA was measured by RT-PCR. Western blot assays was performed to examine the protein expression of FASN, HER2, p-HER2(Y1248), PI3K, Akt and p-Akt (Ser473). Migration and invasion of cells were investigated by wound healing and transwell invasion assays. The results showed that the activity of HER2/PI3K/AKT signaling pathway was suppressed by inhibiting FASN. Meanwhile, the U-2OS cells migration and invasion were also impaired by inhibiting the activity of FASN/HER2/PI3K/AKT. Our results indicated that inhibition of FASN suppresses OS cell invasion and migration via down-regulation of the "HER2/PI3K/AKT" axis in vitro. FASN blocker may be a new therapeutic strategy in OS management.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Fatty acid synthase (FASN); HER2/PI3K/AKT signaling pathway; Invasion; Migration; Osteosarcoma (OS)

Mesh:

Substances:

Year:  2013        PMID: 24041695     DOI: 10.1016/j.bbrc.2013.09.024

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  10 in total

Review 1.  Role of abnormal lipid metabolism in development, progression, diagnosis and therapy of pancreatic cancer.

Authors:  Julian Swierczynski; Areta Hebanowska; Tomasz Sledzinski
Journal:  World J Gastroenterol       Date:  2014-03-07       Impact factor: 5.742

2.  Interaction between fatty acid synthase and human epidermal growth receptor 2 (HER2) in osteosarcoma cells.

Authors:  Xin Hua Long; Kai Zhao; Guo Mei Zhang; Yang Zhou; Rong Ping Zhou; Zhi Li Liu; Zhi Hong Zhang
Journal:  Int J Clin Exp Pathol       Date:  2014-12-01

3.  An Essential Role for the Tumor-Suppressor Merlin in Regulating Fatty Acid Synthesis.

Authors:  Dina S Stepanova; Galina Semenova; Yin-Ming Kuo; Andrew J Andrews; Sylwia Ammoun; C Oliver Hanemann; Jonathan Chernoff
Journal:  Cancer Res       Date:  2017-07-20       Impact factor: 12.701

4.  Blocking fatty acid synthase inhibits tumor progression of human osteosarcoma by regulating the human epidermal growth factor receptor 2/phosphoinositide 3-kinase/protein kinase B signaling pathway in xenograft models.

Authors:  Xuan Yin Chen; Hui Bing Ruan; Xin Hua Long; Ai Fen Peng; Long Dian Zhou; Jia Ming Liu; Yang Zhou; Zhi Li Liu
Journal:  Exp Ther Med       Date:  2017-03-29       Impact factor: 2.447

5.  Inhibition of the mevalonate pathway affects epigenetic regulation in cancer cells.

Authors:  Heidrun Karlic; Roman Thaler; Christopher Gerner; Thomas Grunt; Katharina Proestling; Florian Haider; Franz Varga
Journal:  Cancer Genet       Date:  2015-03-18

6.  Exploring a role for fatty acid synthase in prostate cancer cell migration.

Authors:  Mario De Piano; Valeria Manuelli; Giorgia Zadra; Massimo Loda; Gordon Muir; Ash Chandra; Jonathan Morris; Mieke Van Hemelrijck; Claire M Wells
Journal:  Small GTPases       Date:  2020-10-12

7.  Endothelin A receptor antagonism enhances inhibitory effects of anti-ganglioside GD2 monoclonal antibody on invasiveness and viability of human osteosarcoma cells.

Authors:  Bo Liu; Yi Wu; Yu Zhou; Dan Peng
Journal:  PLoS One       Date:  2014-04-11       Impact factor: 3.240

8.  Downregulation of HADH promotes gastric cancer progression via Akt signaling pathway.

Authors:  Congcong Shen; Yao-Hua Song; Yufeng Xie; Xiaoxiao Wang; Yunliang Wang; Chao Wang; Songbai Liu; Sheng-Li Xue; Yangxin Li; Bin Liu; Zaixiang Tang; Weichang Chen; Jenny Song; Hesham M Amin; Jin Zhou
Journal:  Oncotarget       Date:  2017-07-18

Review 9.  Fatty Acid Synthase: An Emerging Target in Cancer.

Authors:  Chee Wai Fhu; Azhar Ali
Journal:  Molecules       Date:  2020-08-28       Impact factor: 4.411

10.  Annexin A5 promotes invasion and chemoresistance to temozolomide in glioblastoma multiforme cells.

Authors:  Lei Wu; Liang Yang; Yu Xiong; Hua Guo; Xiaoli Shen; Zujue Cheng; Yan Zhang; Ziyun Gao; Xingen Zhu
Journal:  Tumour Biol       Date:  2014-09-23
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.